APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemoperfusion

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Selected research

Market Outlook & Growth Opportunities

Global Hemoperfusion Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchHemoperfusion Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemoperfusion Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Hemoperfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemoperfusion Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemoperfusion Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.

This report provides an overview of the global Hemoperfusion market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hemoperfusion and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemoperfusion sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemoperfusion market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemoperfusion Segment by Company

Jafron Biomedical

Baxter (Gambro)

Asahi-Kasei

Biosun Medical

Kaneka

Toray Medical

Cytosorbents

Aier

Zibo Kangbei

Hemoperfusion Segment by Type

Activated Carbon Adsorption

Resin Adsorption

Hemoperfusion Segment by Application

Hepatic Encephalopathy

Certain Autoimmune Diseases

Drug Overdose

Specific Intoxications

Others

Hemoperfusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hemoperfusion status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hemoperfusion market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hemoperfusion significant trends, drivers, influence factors in global and regions.

6. To analyze Hemoperfusion competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoperfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemoperfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoperfusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemoperfusion market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hemoperfusion industry.

Chapter 3: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hemoperfusion in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hemoperfusion Industry Trends Table 2. Hemoperfusion Industry Drivers Table 3. Hemoperfusion Industry Opportunities and Challenges Table 4. Hemoperfusion Industry Restraints Table 5. Global Hemoperfusion Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hemoperfusion Revenue Share by Company (2021-2026) Table 7. Global Hemoperfusion Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Hemoperfusion Sales Volume Share by Company (2021-2026) Table 9. Global Hemoperfusion Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Hemoperfusion Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hemoperfusion Key Company Manufacturing Base & Headquarters Table 12. Global Hemoperfusion Company, Product Type & Application Table 13. Global Hemoperfusion Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Activated Carbon Adsorption Table 18. Significant Companies of Resin Adsorption Table 19. Global Hemoperfusion Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hemoperfusion Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Hemoperfusion Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Hemoperfusion Sales Volume Share by Type (2021-2026) Table 23. Global Hemoperfusion Sales Volume Share by Type (2027-2032) Table 24. Global Hemoperfusion Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Hemoperfusion Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Hemoperfusion Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Hemoperfusion Sales Value Share by Type (2021-2026) Table 28. Global Hemoperfusion Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hepatic Encephalopathy Table 30. Significant Companies of Certain Autoimmune Diseases Table 31. Significant Companies of Drug Overdose Table 32. Significant Companies of Specific Intoxications Table 33. Significant Companies of Others Table 34. Global Hemoperfusion Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Hemoperfusion Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Hemoperfusion Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Hemoperfusion Sales Volume Share by Application (2021-2026) Table 38. Global Hemoperfusion Sales Volume Share by Application (2027-2032) Table 39. Global Hemoperfusion Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Hemoperfusion Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Hemoperfusion Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Hemoperfusion Sales Value Share by Application (2021-2026) Table 43. Global Hemoperfusion Sales Value Share by Application (2027-2032) Table 44. Global Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Hemoperfusion Sales by Region (2021-2026) & (K Units) Table 46. Global Hemoperfusion Sales Market Share by Region (2021-2026) Table 47. Global Hemoperfusion Sales by Region (2027-2032) & (K Units) Table 48. Global Hemoperfusion Sales Market Share by Region (2027-2032) Table 49. Global Hemoperfusion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Hemoperfusion Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Hemoperfusion Sales Value Share by Region (2021-2026) Table 52. Global Hemoperfusion Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Hemoperfusion Sales Value Share by Region (2027-2032) Table 54. Global Hemoperfusion Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Hemoperfusion Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Hemoperfusion Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 59. Global Hemoperfusion Sales Market Share by Country (2021-2026) Table 60. Global Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 61. Global Hemoperfusion Sales Market Share by Country (2027-2032) Table 62. Global Hemoperfusion Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Hemoperfusion Sales Value Market Share by Country (2021-2026) Table 64. Global Hemoperfusion Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Hemoperfusion Sales Value Market Share by Country (2027-2032) Table 66. Jafron Biomedical Company Information Table 67. Jafron Biomedical Business Overview Table 68. Jafron Biomedical Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Jafron Biomedical Hemoperfusion Product Portfolio Table 70. Jafron Biomedical Recent Development Table 71. Baxter (Gambro) Company Information Table 72. Baxter (Gambro) Business Overview Table 73. Baxter (Gambro) Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Baxter (Gambro) Hemoperfusion Product Portfolio Table 75. Baxter (Gambro) Recent Development Table 76. Asahi-Kasei Company Information Table 77. Asahi-Kasei Business Overview Table 78. Asahi-Kasei Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Asahi-Kasei Hemoperfusion Product Portfolio Table 80. Asahi-Kasei Recent Development Table 81. Biosun Medical Company Information Table 82. Biosun Medical Business Overview Table 83. Biosun Medical Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Biosun Medical Hemoperfusion Product Portfolio Table 85. Biosun Medical Recent Development Table 86. Kaneka Company Information Table 87. Kaneka Business Overview Table 88. Kaneka Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Kaneka Hemoperfusion Product Portfolio Table 90. Kaneka Recent Development Table 91. Toray Medical Company Information Table 92. Toray Medical Business Overview Table 93. Toray Medical Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Toray Medical Hemoperfusion Product Portfolio Table 95. Toray Medical Recent Development Table 96. Cytosorbents Company Information Table 97. Cytosorbents Business Overview Table 98. Cytosorbents Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Cytosorbents Hemoperfusion Product Portfolio Table 100. Cytosorbents Recent Development Table 101. Aier Company Information Table 102. Aier Business Overview Table 103. Aier Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Aier Hemoperfusion Product Portfolio Table 105. Aier Recent Development Table 106. Zibo Kangbei Company Information Table 107. Zibo Kangbei Business Overview Table 108. Zibo Kangbei Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Zibo Kangbei Hemoperfusion Product Portfolio Table 110. Zibo Kangbei Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Hemoperfusion Distributors List Table 114. Hemoperfusion Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Hemoperfusion Product Image Figure 2. Global Hemoperfusion Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hemoperfusion Sales (2021-2032) & (K Units) Figure 5. Global Hemoperfusion Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Hemoperfusion Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Activated Carbon Adsorption Image Figure 10. Resin Adsorption Image Figure 11. Global Hemoperfusion Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Hemoperfusion Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Hemoperfusion Sales Volume Share by Type (2021-2032) Figure 14. Global Hemoperfusion Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Hemoperfusion Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Hemoperfusion Sales Value Share by Type (2021-2032) Figure 17. Hepatic Encephalopathy Image Figure 18. Certain Autoimmune Diseases Image Figure 19. Drug Overdose Image Figure 20. Specific Intoxications Image Figure 21. Others Image Figure 22. Global Hemoperfusion Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hemoperfusion Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Hemoperfusion Sales Volume Share by Application (2021-2032) Figure 25. Global Hemoperfusion Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Hemoperfusion Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Hemoperfusion Sales Value Share by Application (2021-2032) Figure 28. Global Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Hemoperfusion Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Hemoperfusion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Hemoperfusion Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 33. North America Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 39. South America Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Hemoperfusion Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Hemoperfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Hemoperfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Hemoperfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Hemoperfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Hemoperfusion Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Hemoperfusion Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Activated Carbon Adsorption
  • Resin Adsorption
Applications
  • Hepatic Encephalopathy
  • Certain Autoimmune Diseases
  • Drug Overdose
  • Specific Intoxications
  • Others
Companies covered
  • Jafron Biomedical
  • Baxter (Gambro)
  • Asahi-Kasei
  • Biosun Medical
  • Kaneka
  • Toray Medical
  • Cytosorbents
  • Aier
  • Zibo Kangbei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemoperfusion Sales Value (2021-2032)
  4. 1.2.2 Global Hemoperfusion Sales Volume (2021-2032)
  5. 1.2.3 Global Hemoperfusion Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hemoperfusion Market Dynamics
  1. 2.1 Hemoperfusion Industry Trends
  2. 2.2 Hemoperfusion Industry Drivers
  3. 2.3 Hemoperfusion Industry Opportunities and Challenges
  4. 2.4 Hemoperfusion Industry Restraints
3 Hemoperfusion Market by Company
  1. 3.1 Global Hemoperfusion Company Revenue Ranking in 2025
  2. 3.2 Global Hemoperfusion Revenue by Company (2021-2026)
  3. 3.3 Global Hemoperfusion Sales Volume by Company (2021-2026)
  4. 3.4 Global Hemoperfusion Average Price by Company (2021-2026)
  5. 3.5 Global Hemoperfusion Company Ranking (2024-2026)
  6. 3.6 Global Hemoperfusion Company Manufacturing Base and Headquarters
  7. 3.7 Global Hemoperfusion Company Product Type and Application
  8. 3.8 Global Hemoperfusion Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hemoperfusion Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hemoperfusion Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hemoperfusion Market by Type
  1. 4.1 Hemoperfusion Type Introduction
  2. 4.1.1 Activated Carbon Adsorption
  3. 4.1.2 Resin Adsorption
  4. 4.2 Global Hemoperfusion Sales Volume by Type
  5. 4.2.1 Global Hemoperfusion Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hemoperfusion Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Hemoperfusion Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Hemoperfusion Sales Value by Type
  9. 4.3.1 Global Hemoperfusion Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hemoperfusion Sales Value by Type (2021-2032)
  11. 4.3.3 Global Hemoperfusion Sales Value Share by Type (2021-2032)
5 Hemoperfusion Market by Application
  1. 5.1 Hemoperfusion Application Introduction
  2. 5.1.1 Hepatic Encephalopathy
  3. 5.1.2 Certain Autoimmune Diseases
  4. 5.1.3 Drug Overdose
  5. 5.1.4 Specific Intoxications
  6. 5.1.5 Others
  7. 5.2 Global Hemoperfusion Sales Volume by Application
  8. 5.2.1 Global Hemoperfusion Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hemoperfusion Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Hemoperfusion Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Hemoperfusion Sales Value by Application
  12. 5.3.1 Global Hemoperfusion Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hemoperfusion Sales Value by Application (2021-2032)
  14. 5.3.3 Global Hemoperfusion Sales Value Share by Application (2021-2032)
6 Hemoperfusion Regional Sales and Value Analysis
  1. 6.1 Global Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemoperfusion Sales by Region (2021-2032)
  3. 6.2.1 Global Hemoperfusion Sales by Region: 2021-2026
  4. 6.2.2 Global Hemoperfusion Sales by Region (2027-2032)
  5. 6.3 Global Hemoperfusion Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hemoperfusion Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hemoperfusion Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hemoperfusion Sales Value by Region (2027-2032)
  9. 6.5 Global Hemoperfusion Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hemoperfusion Sales Value (2021-2032)
  12. 6.6.2 North America Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hemoperfusion Sales Value (2021-2032)
  15. 6.7.2 Europe Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hemoperfusion Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hemoperfusion Sales Value (2021-2032)
  21. 6.9.2 South America Hemoperfusion Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hemoperfusion Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hemoperfusion Sales Value Share by Country, 2025 VS 2032
7 Hemoperfusion Country-level Sales and Value Analysis
  1. 7.1 Global Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hemoperfusion Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hemoperfusion Sales by Country (2021-2032)
  4. 7.3.1 Global Hemoperfusion Sales by Country (2021-2026)
  5. 7.3.2 Global Hemoperfusion Sales by Country (2027-2032)
  6. 7.4 Global Hemoperfusion Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hemoperfusion Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hemoperfusion Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hemoperfusion Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hemoperfusion Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hemoperfusion Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hemoperfusion Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hemoperfusion Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hemoperfusion Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hemoperfusion Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hemoperfusion Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hemoperfusion Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hemoperfusion Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hemoperfusion Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hemoperfusion Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hemoperfusion Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hemoperfusion Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hemoperfusion Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hemoperfusion Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hemoperfusion Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hemoperfusion Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hemoperfusion Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hemoperfusion Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hemoperfusion Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hemoperfusion Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hemoperfusion Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hemoperfusion Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hemoperfusion Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hemoperfusion Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hemoperfusion Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hemoperfusion Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hemoperfusion Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hemoperfusion Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hemoperfusion Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jafron Biomedical
  2. 8.1.1 Jafron Biomedical Company Information
  3. 8.1.2 Jafron Biomedical Business Overview
  4. 8.1.3 Jafron Biomedical Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jafron Biomedical Hemoperfusion Product Portfolio
  6. 8.1.5 Jafron Biomedical Recent Developments
  7. 8.2 Baxter (Gambro)
  8. 8.2.1 Baxter (Gambro) Company Information
  9. 8.2.2 Baxter (Gambro) Business Overview
  10. 8.2.3 Baxter (Gambro) Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter (Gambro) Hemoperfusion Product Portfolio
  12. 8.2.5 Baxter (Gambro) Recent Developments
  13. 8.3 Asahi-Kasei
  14. 8.3.1 Asahi-Kasei Company Information
  15. 8.3.2 Asahi-Kasei Business Overview
  16. 8.3.3 Asahi-Kasei Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Asahi-Kasei Hemoperfusion Product Portfolio
  18. 8.3.5 Asahi-Kasei Recent Developments
  19. 8.4 Biosun Medical
  20. 8.4.1 Biosun Medical Company Information
  21. 8.4.2 Biosun Medical Business Overview
  22. 8.4.3 Biosun Medical Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Biosun Medical Hemoperfusion Product Portfolio
  24. 8.4.5 Biosun Medical Recent Developments
  25. 8.5 Kaneka
  26. 8.5.1 Kaneka Company Information
  27. 8.5.2 Kaneka Business Overview
  28. 8.5.3 Kaneka Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kaneka Hemoperfusion Product Portfolio
  30. 8.5.5 Kaneka Recent Developments
  31. 8.6 Toray Medical
  32. 8.6.1 Toray Medical Company Information
  33. 8.6.2 Toray Medical Business Overview
  34. 8.6.3 Toray Medical Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Toray Medical Hemoperfusion Product Portfolio
  36. 8.6.5 Toray Medical Recent Developments
  37. 8.7 Cytosorbents
  38. 8.7.1 Cytosorbents Company Information
  39. 8.7.2 Cytosorbents Business Overview
  40. 8.7.3 Cytosorbents Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cytosorbents Hemoperfusion Product Portfolio
  42. 8.7.5 Cytosorbents Recent Developments
  43. 8.8 Aier
  44. 8.8.1 Aier Company Information
  45. 8.8.2 Aier Business Overview
  46. 8.8.3 Aier Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Aier Hemoperfusion Product Portfolio
  48. 8.8.5 Aier Recent Developments
  49. 8.9 Zibo Kangbei
  50. 8.9.1 Zibo Kangbei Company Information
  51. 8.9.2 Zibo Kangbei Business Overview
  52. 8.9.3 Zibo Kangbei Hemoperfusion Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zibo Kangbei Hemoperfusion Product Portfolio
  54. 8.9.5 Zibo Kangbei Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemoperfusion Value Chain Analysis
  2. 9.1.1 Hemoperfusion Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemoperfusion Sales Mode & Process
  6. 9.2 Hemoperfusion Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemoperfusion Distributors
  9. 9.2.3 Hemoperfusion Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst